Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Martin

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Urology|July 1, 2014
Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groupsBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.
Cancer Medicine|September 13, 2022
Comprehensive association analysis of speech recognition thresholds after cisplatin-based chemotherapy in survivors of adult-onset cancerMohammad Shahbazi, Xindi Zhang, Paul C Dinh, et al.
Cancer|May 29, 2020
Treating the SARS-CoV-2-positive patient with cancer: A proposal for a pragmatic and transparent ethical processSubha Perni, Michael G Milligan, Anurag Saraf, et al.
European Urology Focus|July 30, 2017
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Urologic Oncology|May 22, 2014
Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Journal of Geriatric Oncology|May 28, 2014
Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Urologic Oncology|May 24, 2017
Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomyDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
European Urology|February 27, 2018
Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate CancerBrandon A Mahal, David D Yang, Natalie Q Wang, et al.
Radiology|October 29, 2024
AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate CancerDavid D Yang, Leslie K Lee, James M G Tsui, et al.
Nature Communications|September 6, 2017
Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancerSvitlana Tyekucheva, Michaela Bowden, Clyde Bango, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Urology|July 1, 2014
Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groupsBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.
Cancer Medicine|September 13, 2022
Comprehensive association analysis of speech recognition thresholds after cisplatin-based chemotherapy in survivors of adult-onset cancerMohammad Shahbazi, Xindi Zhang, Paul C Dinh, et al.
Cancer|May 29, 2020
Treating the SARS-CoV-2-positive patient with cancer: A proposal for a pragmatic and transparent ethical processSubha Perni, Michael G Milligan, Anurag Saraf, et al.
European Urology Focus|July 30, 2017
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Urologic Oncology|May 22, 2014
Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Journal of Geriatric Oncology|May 28, 2014
Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Urologic Oncology|May 24, 2017
Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomyDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
European Urology|February 27, 2018
Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate CancerBrandon A Mahal, David D Yang, Natalie Q Wang, et al.
Radiology|October 29, 2024
AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate CancerDavid D Yang, Leslie K Lee, James M G Tsui, et al.
Nature Communications|September 6, 2017
Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancerSvitlana Tyekucheva, Michaela Bowden, Clyde Bango, et al.
Pageof 13